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The binding properties towards human telomeric G-quadruplex of the two natural alkaloids Coptisine and 
Chelerythrine were investigated and compared with respect to those of their parent compounds Berberine 
and Sanguinarine. A variety of investigation methods were used, e.g. spectroscopic techniques, X-ray 
diffraction analyses and molecular modelling. Spectroscopic studies showed modest, but different 
rearrangements of the DNA-ligand complexes which can be clearly referred to the peculiar stereochemical 
features for these two alkaloids, in spite of the similarity of their skeletons. In fact, the closure into a 
dioxolo ring of the two methoxy functions rises the efficiency of Coptisine and Sanguinarine in comparison 
to Berberine and Chelerythrine, and the overall stability trend result to be Sanguinarine > Chelerythrine ≈ 
Coptisine > Berberine. Accordingly, the X-ray diffraction results confirmed the involvement of the 
benziodioxolo groups in the Coptisine/DNA binding by means of π…π, O…π and CH…O interactions. Similar 
information is provided by modelling studies, which, additionally, evidenced reasons for the quadruplex vs 
double-helix selectivity shown by these alkaloids. Thus, findings of this study shed light on the key role of 
the benzodioxolo moieties in strengthening the interaction with the G4-folded human telomeric sequence 
and pointed out the better G4 stabilizer properties of the benzophentridine scaffold with respect to the 
protoberberine one. Moreover these results were found able to explain the ds vs. G4 selectivity trend of 
the investigated alkaloids. 
 
Introduction 
The interest toward G-rich DNA sequences, able to fold in the so-called G-quadruplex structures, 
tremendously grew during the last decades. Among the several G-quadruplex forming sequences identified 
in human genome, the telomeric DNA is one of the most studied [1,2]. Telomere are found at the end of 
chromosomes and in eukaryotic cells are formed by (TTAGGG) repeats. Here, the 3’ terminal is present as a 
protruding single strand and represents the substrate of telomerase. This enzyme is a ribonucleoprotein 
activated in more than 80% of tumors, where it maintains telomere length by a reverse transcriptase 
activity. Folding of the 3’ protruding single-stranded telomeric DNA into a G-quadruplex structure is known 
to inhibit telomerase activity and it has recently been suggested as an innovative therapeutic anticancer 
strategy [2]. Consequently, ligands that bind and induce telomeric G-quadruplexes are extensively explored 
as potential anticancer drugs. Since telomeric activity is predominantly present in cancer cells, in principle, 
they are expected to be targeted agents with reduced side effects [3-6]. On the other hand, good G-
quadruplex binders usually have structural and chemical features that are very similar to those requested 
to double stranded DNA intercalators, i.e. a large aromatic surfaces and, possibly, positive charges. Thus, 
large research efforts are directed to rationally prevent potential off-target effects. 
A number of compounds have been shown to either stabilize G-quadruplex structures or promote their 
formation. Among them, natural compounds are an important resource due to the considerable variability 
in their chemical structure, their wide availability from natural sources, the low cost of their extraction 
processes, and most importantly, their general low toxicity [7]. 
The plant-derived alkaloids, such as isoquinoline derivatives, belong to one of the most widespread building 
blocks and possess prominent biological and pharmacological activities, with a role of remarkable 
importance in the contemporary biomedical research and drug discovery programs [8-11]. Antimicrobial, 
anti-inflammatory, anti-oxidative and anti-diabetic activities have been reported for compounds belonging 
to this group [12-14]. In addition, anticancer properties are ascribed to their ability to form complexes with 
DNA and RNA [9,13,15] and also to their antimicrobial effects on tumorigenic microorganisms as well as to 
their potential regulation of oncogene and carcinogenesis-related genes expression [16]. 
Up to now, however, most of the studies carried out on the DNA telomeric G-quadruplex/alkaloids 
complexes, have mainly focused on the planar isoquinoline alkaloid Berberine and its protoberberine 
derivatives, as well as on the benzophenanthridine alkaloid Sanguinarine (Scheme 1) [17-20]. Coptisine 
(6,7-Dihydro-bis(1,3)benzodioxolo (5,6-a:4',5'-g)quinolizinium) and Chelerythrine (1,2-dimethoxy-12-
methyl- [1,3]benzodioxolo[5,6-c]phenanthridin-12-ium) are structural analogs of Berberine and 
Sanguinarine, respectively. The two partners of each homologous pair differ only for the overall number of 
methylene dioxy or methoxyl substituents (Scheme 1). They are known to be DNA binders, with cytotoxic 
and apoptotic abilities which make them interesting also for modulation of multidrug resistance in several 
cancer cells [21]. Moreover, recent in solution and modeling investigations carried out on Chelerythrine, 
provided evidence of its binding ability towards telomeric DNA [22-25]. 
We previously reported that Sanguinarine, bearing two methylene dioxy moieties, was a better stabilizer 
with respect to Berberine for the G-quadruplex structure assumed by the human telomeric sequence [20]. 
Here, we investigated the binding properties towards human telomeric G-quadruplex of the two analogues 






Results and Discussion 
 
In potassium containing solutions, both Chelerythrine and Coptisine stabilize G4-folded human telomeric 
sequence to a significant extent. In particular, by a fluorescence melting assay we pointed out that 
Chelerythrine and Coptisine have quite similar effects on the telomeric G4 and induce intermediate thermal 
stabilizations (Tm) when referred to the previously reported parent compounds Sanguinarine and 
Berberine (Figure 1 panel a) [20]. The resulting overall stability trend is 
Sanguinarine>Chelerythrine≈Coptisine>Berberine.  Chelerythrine being slightly more efficient than 
Coptisine. Thus, the closure of the two methoxy functions into a dioxolo ring rises the efficiency of 
Coptisine and Sanguinarine in comparison to Berberine and Chelerythrine, respectively, in line with a 
previously reported evidence indicating that the presence of benzo[1,3]dioxole groups in alkaloid 
derivatives promotes the interaction with  G-quadruplex structures from human telomeric DNA [26]. 
In the same experimental conditions, all four alkaloids share a significantly reduced effect on a random 
































Figure 1: (a) Thermal stabilization of the human telomeric sequence HTS in the presence of increasing 
concentrations of tested alkaloids in 10 mM LiOH; 50 mM KCl, pH 7.5. (a) Shift of the melting temperature 
induced by 5 M ligands on dsDNA or on HTS in50 mM KCl or 50 mM NaCl is reported. (data for Berberine 
and Sanguinarine taken from ref. 20). 
 
The presence of K+ or Na+ in the buffer, profoundly alters the G-quadruplex folding of the telomeric 
sequence shifting it from a hybrid towards an antiparallel arrangement, respectively. For Chelerythrine, by 
using different techniques Bai et al. found an affinity ranking order for telomeric DNA corresponding to 
hybrid K+ >> basket Na+ [25]. This same trend is here confirmed for all tested alkaloids resulting in a 
relevant preference for the hybrid conformation (Figure 1 panel b). 
However, it is well known that the so called hybrid form assumed by the telomeric sequence in K+ 
containing solutions, actually comprises several distinct folded species in equilibrium with low energetic 
barriers [27]. Among them two different 3 + 1 foldings, named hybrid 1 and hybrid 2, are highly 
represented in solution; their relative abundance is a function of the length and sequence of the nucleic 
acid [28].  
With this issue in mind, we decided to deeply investigate if the preferential recognition of the K+ induced G-
quadruplex observed for Chelerythrine and Coptisine is in some way dependent on the folding assumed by 
the telomeric sequence. To this aim, we performed a FID competition assay by using two different 
sequences, namely Tel26 and wtTel26, known to fold into a prevalent H1 or H2 hybrid form, respectively. 
As fluorescent probe for these G4 structures, we used Thiazole Orange that shows comparable binding 
affinity for both of them. As shown in Table 1, both Chelerythrine and Coptisine were able to displace the 
dye from the folded telomeric sequences. Coptisine showed lower efficiency in comparison to 
Chelerythrine on both substrates, mostly on H1 hybrid form. Interestingly, for this compound, a more 
significant preference for the H2 form emerged. 
TABLE 1 - EC50 derived by FID for the interaction of Chelerythrine and Coptisine with the hybrid 1 (H1) and 
hybrid 2 (H2) folding of telomeric DNA. 
  H1 H2 H2 vs H1 
Chelerythrine 2.59 ± 0.10 M 3.75 ± 0.24 M 0.7 
Coptisine 12.01 ± 0.82 M 5.93 ± 0.36 M 2.0 
 
In line, CD titration of the two G4 forms with the tested alkaloids confirmed their interaction with the two 
DNA templates as supported by a conserved increment of the positive band centered at 295 nm and a 
reduction of the 260 nm band (Figure 2). However, subtle differences in the binding modes of the two DNA 
templates by the two ligands emerged. Indeed, at saturations the final CDs are slightly different thus 
actually supporting a modest rearrangement of the DNA-ligand complex and suggesting that the G-




Figure 2: CD spectra of 4 M (A) Tel26 (H1) and (B) wtTel26 (H2) in 10 mM Tris, 50 mM KCl, pH 7.5, in the 
absence (solid lines) or in the presence of 40 M Chelerythrine (dashed lines) or Coptisine (dotted lines) 
A similar modulation in DNA recognition occurs also on dsDNA. Indeed, despite a reduced interaction of the 
two alkaloids with this template in comparison to the G4, distinct UV and CD features characterize the two 
alkaloid-dsDNA complexes (Figure S1 ESI). These differences can be clearly referred to the peculiar 
stereochemical features for these two alkaloids, in spite of the similarity of their skeletons. Indeed, 
previously reported crystallographic data indicate that whereas Chelerythrine interact with DNA in its 
planar and charged iminium form (Scheme 1), Coptisine is not planar and features a 18° dihedral angle 
between its phenyl and quinoline moieties [29]. 
To further highlight the molecular basis governing the binding of Chelerythrine and Coptisine on telomeric 
G-quadruplex, molecular modeling investigations were carried out on the two structurally characterized 
hybrid arrangements associated to the Tel26 (H1) and wtTel26 (H2) telomeric sequences (see Methods 
section). Despite Chelerythrine adopts in its adduct with H1 a not completely flat conformation 
(naphthalene and benzodioxolo moieties form a dihedral angle of about 16°), it is very well placed on the 
quartet formed by G4-G10-G18-G22 residues (Figure 3) establishing π-π interactions mainly with the G22 
guanine and with G4 (interplanar distances ranging from 3.4 to 3.9 Å). The flanking A3 adenine residue 
wraps over the ligand. The overall binding is then reinforced by a salt-bridge involving the charged ligand 




Figure 3 - Calculated conformers for the complexes of Chelerythrine with H1 - lateral (a) and top view (b) – 
and with H2 - lateral (c) and top view (d) –. (adenine, tymine and guanine residues are in red, cyan and 
gray, respectively) 
 
In the adduct formed with H2, Chelerythrine is not in direct contact with the guanine quartet formed by G4-
G12-G16-G22 residues, but it gives face to face stacking (3.4 Å interplanar distance) with the adenine-A15 
(Figure 3 c,d). 
In the lowest energy conformer found for the Coptisine/H1 adduct (Figure 4 a,b), the most important 
interactions seem to be two H-bonds involving the two dioxolo groups and A21 adenine (2.05 Å) or T7 
thymine (2.18 Å). These two interactions fix the molecule in a quite bent conformation (about 23° between 
the quinoline and benzodioxolo group) thus preventing the optimal stacking with the 5’-end tetrad. In fact, 
the quinoline moiety stacks with just the G10 guanine (3.7 Å interplanar distance). Moreover, CH…π contact 
(2.7 Å) is formed between the methylene group from a benzodioxolo and A9 adenine (Figure 4a). 
 
Figure 4 - Calculated conformers for the complexes of Coptisine with H1 - lateral (a) and top view (b) – and 
with H2 - lateral (c) and top view (d) – (adenine, tymine and guanine residues are in red, cyan and gray, 
respectively) 
A less bent conformation is instead assumed by Coptisine in the adduct formed with H2 (about 17° 
between the quinoline and benzodioxolo group -Figure 4 c,d). In this adduct the ligand reaches the guanine 
quartet, giving a stacking interaction with G22 and G16. (interplanar distances 3.7 Å). In a similar fashion as 
for Chelerythrine, A15 flanking base at 5’-end wraps Coptisine establishing a π-stacking interaction at about 
3.6 Å interplanar distance. 
Basing on these findings the Coptisine scaffold seems better suited for the H2 arrangement of the telomeric 
DNA thus supporting the solution study’s results which highlight the remarkable preference of Coptisine for 
the H2 over H1 folding. 
Interesting comparison can be derived for the interaction behavior of these two alkaloids with respect to 
their parent compounds Berberine and Sanguinarine. In fact, it is noteworthy that stable poses not 
involving the guanine quartets have been found for both the benzophenantridine compounds Sanguinarine 
and Chelerythrine. Indeed, in a previously reported study, Sanguinarine was found to act as groove binder 
of the hybrid arrangement [20]. Moreover, NMR experiments pointed out that in the case of the basket 
arrangement, Sanguinarine locates close to the loop residue A7. These binding preferences can explain the 
low double helix over G-quadruplex selectivity especially found for Sanguinarine. On the other hand, 
Berberine and Coptisine, invariably interact with the quartet and are able to well discriminate double helix 
vs. quadruplex structures. 
In addition, solution data indicate that the presence of the two benzodioxole rings rises the stability of 
Coptisine and Sanguinarine adducts with respect to those formed by Berberine and Chelerythrine, 
respectively. In line with these observations, modelling results evidence that the methylene dioxy group is 
involved in the interaction with the target only in the case of Sanguinarine and Coptisine while Berberine 
and Chelerythrine, bearing two methoxy groups, lack this kind of contact. 
 
To fully explore the structural arrangement of adducts formed by Coptisine and Chelerythrine with the 
telomeric DNA, crystallization screenings were carried out for both alkaloids by using the Tel12 and Tel23 
sequences, which afford bimolecular and monomolecular G4 structures, respectively. Crystals suitable for 
X-ray diffraction analysis were obtained only for the adduct of Coptisine with the 12-mer human telomeric 
sequence d(TAGGGTTAGGGT). The crystal structure is built up by parallel stranded-bimolecular 
quadruplexes and ligand molecules in 1:1 molar ratio. Each quadruplex unit contains the three planar 
stacked G-quartets, 3.4 Å apart from each other, typical of human telomeric quadruplex. As shown in Figure 
5, the quadruplex is formed by two symmetry independent chains, where the TTA sequences connecting 
the guanine tracts form propeller loops which protrude outwards. The propeller TTA loops can be described 
as type 5 and type 1 (subtype 2), according to the analysis reported by Neidle and coworkers [30]. 
Analogously to the previous reported telomeric quadruplex structures, monovalent K+ cations are found in 
the internal channel located between two adjacent guanine tetrads, 2.7-3.0 Å apart from the eight O6 
carbonyl oxygens which determine an antiprismatic coordination sphere. 
One of the 3’-end terminal thymine residue (T12, light gray chain in Figure 5A) stacks on the underlying G-
quartet, while the other (T24, dark gray chain in Figure 5A) protrudes outside providing a binding point with 




Figure 5- Crystal structure of the Tel12/Coptisine adduct. Top view of the T12 residue and the Coptisine 
molecule stacked on the 3’-end tetrad of the target molecule (a) and of the TATA quartet at the 5’-end 
tetrad (b). View of the binding site (c). Dotted lines indicate the H-bond contacts between the thymine and 
adenine residues (distances range from 2.7 Å to 3.1 Å). The two symmetry independent Tel12 chains are 
light and dark gray colored. T and A residues are colored in cyan and red, respectively. 
 
As the 5’-end is concerned, the thymine and adenine residues from the two chains interact via Watson-
Crick H-bonds forming an additional tetrad which stacks on the G-quartet (Figure 5B). Differently from the 
G-quartets, which are formed by four almost perfectly coplanar guanines, in the TATA platform each 
adenine forms with the adjacent thymines dihedral angles with values falling in the range 14-23°. The 
quadruplex units are head-to-tail disposed in column which grow along the 4-fold screw axis, with the 
Coptisine molecule and the T12 residue sandwiched between the 3’-end G-quartet and the 5’-end TATA 
tetrad from the following quadruplex unit (ESI - Figure. S3).  
As a consequence, the binding site of Coptisine is defined by the 3’-end G-quartet and the 5’-end TATA 
platform belonging to adjacent units in the column, with the alkaloid being approximately 3.4 Å apart from 
each quartet (Figure 5c). Coptisine is asymmetrically placed respect to the four guanines and in contact 
with only two of them, each belonging to a different chain. On the other side, Coptisine gives contacts with 
the two adenine residues of the 5’-end TATA platform. The cationic nitrogen is located approximately in 
line with potassium ions in the central channel, and points towards one of the O4 carbonyl oxygen of the 
T12. Interestingly, this thymine residue and the Coptisine interact via CH…O hydrogen bonds (C…O distances 
3.3 Å).  
In the present complex Coptisine is quite planar, featuring a 13° dihedral between the phenyl and the 
quinoline groups (Scheme 1). QM calculations have demonstrated that Coptisine can assume bent 
conformations [29] and among these, the most stable is characterized by the greater dihedral angle (about 
30°). Interestingly, this bent conformation was found to bind an unusual C:G:G:C tetrad formed by adjacent 
double helices of CGATCG sequence in the crystal structure of the CGATCG/coptisine adduct (Figure 6 and 
Figure S4 - ESI) [29]. As shown in Figure 8, in the binding site Coptisine is stabilized by π…π and O…π 
interactions, so confirming, together with the presence of CH…O analogous to the interaction evidenced in 




Figure 6 - C:G:G:C platforms defining the binding site for Coptisine in the CGATCG/coptisine adduct (data 
from ref. 27).   
 
Thus, the almost planar conformation assumed in the solved structure is most likely due to the π-stacking 
interactions established with both 3’-end GGGG and 5’-end TATA quartets. The planar conformation is 
usually found in the solid state structures of alkaloids belonging to the protoberberine family reported in 
the Cambridge Structural Database [31]. In these cases, the crystal packing forces play a relevant role 
influencing the overall conformation of the crystallized species. 
Among the crystal structures previously reported for telomeric quadruplex in complex with ligand, that of 
the adduct formed by the Tel12 sequence and BRACO-19 is the most similar to the Coptisine adduct. 
Actually, also the BRACO ligand in its binding site is in contact with a thymine residue, both ligand and 
thymine being sandwiched between a G-quartet and a TATA platform of symmetry related G-quadruplex 
units. On the other hand, the most interesting difference between the two structures is that in the BRACO 
complex the residues giving the TATA platform belong to two head-to-tail quadruplexes, particularly a 3’-
end thymine and the 5’-end ATA group, while in the Coptisine/Tel12 adduct all the residues forming the 
TATA platform belong to and stack on the same G-quadruplex. In line with this finding the TATA platform 
evidenced in our crystal structure could be maintained also in the isolated quadruplexes present in diluted 
solution, thus constituting a potential binding site.  
To analyze the possible formation in diluted solution of a sandwich comprising two G4 units and one 
Coptisine, we performed EMSA and CD experiments . The formation of such kind a sandwich was ruled out 
in diluted solution (up to 10 M oligonucleotide) both in the absence and in the presence of MPD, the same 
cosolvent used to obtain the crystal. Indeed, on gel (ESI, Figure S5) we never solved the dimer that is 
expected to have a reduced electrophoretic mobility due to its increased hydrodynamic volume. 
Conversely, the cosolvent was actually able to induce the complete folding of the oligonucleotide into a G-
quadruplex. In these conditions, the corresponding CD is characterized by two well resolved main positive 
bands centered at 295 and 260 nm. Although the G-quadruplex- Coptisine interaction was evidenced by the 
increment of the CD bands intensities, the maxima/minima wavelengths were preserved up to a 10-fold 
excess of ligand vs G4, so confirming that Coptisine is not altering significantly the overall geometry of the 
nucleic acid in our experimental conditions (Figure 7). 
Nevertheless, it is interesting to note that crystal structures containing A/T-based platforms analogous to 
what found in our Coptisine/Tel12 complex, have been also recently observed by Neidle and coworkers 
[32]. As in our structure, the A/T-based platforms are formed by residues belonging to the same chain. 
Moreover, the platforms are stacked on the telomeric G4 in a very similar way to what found in our 
Coptisine/Tel12 complex. Noteworthy, the A/T-based platforms constitute the junction between a human 







Figure 7 -  CD spectra of 8 M Tel12 recorded in 10 mM Tris, 50 mM KCl, 40 % MPD in the absence (solid 
line) or presence (dotted line) of 40 M Chelerythrine. 
Conclusion 
The two studied alkaloids Chelerythrine and Coptisine are able to bind the human telomeric sequence 
arranged in quadruplex foldings. Similarly to the data previously reported for the parent compounds 
Sanguinarine and Berberine, the ΔTm values here reported point out the slightly higher stabilization ability 
of Chelerythrine over Coptisine and the benzophenanthridine scaffold is confirmed to better interact with 
the telomeric G quadruplex than the protoberberine one. The Sanguinarine > Berberine stabilizing trend 
was previously interpreted as a consequence of the different degree of planarity and/or π-delocalization 
between the scaffolds of the two ligands. The here obtained results clearly highlights that planarity is not 
the only important feature, and other aspects should be taken into account. Indeed, comparing ligands 
characterized by the same scaffold, stronger interactions are always found when an additional 
benzodioxolo ring replace the two methoxy functions (stability trend Sanguinarine > Chelerythrine and 
Coptisine > Berberine). Interestingly, both in silico modelling and X-ray diffraction analysis demonstrate 
that the benzodioxolo groups of Coptisine can be involved in contacts which stabilize the formed adducts. 
The theoretical investigation and the structural analysis of the Coptisine/Tel12 complex, as well as the 
adduct Berberine/Tel23 already present in literature, show that both ligands are able to give quite good 
stacking on the guanine tetrads. In the case of Chelerythrine, the ligand can establish interactions with both 
the quartet and loop residues in that making it more similar to the Sanguinarine, the less selective among 
these four alkaloids. In conclusion, our work has shed light on the interaction between human telomeric G-
quadruplex folding and selected natural alkaloids with interesting anticancer activity. The results show that 
Coptisine is the most valuable candidate for further studies as G4-binding compound, moreover we have 
obtained important clues for the design of new G-quadruplex ligands with better binding properties.  
Methods 
Materials. All synthetic DNA were provided by Biosense (wtTel26 (H2) (5’-
TTAGGGTTAGGGTTAGGGTTAGGGTT-3’), Tel26 (H1) (5’-AAAGGGTTAGGGTTAGGGTTAGGGAA-3’), HTS (5’-
Dabcyl-AGGGTTAGGGTTAGGGTTAGGGT–FAM-3’) and scT22 (5’-Dabcyl-GGATGTGAGTGTGAGTGTGAGG 
paired to the complementary strand labelled with FAM at 3’) and by Jena Bioscience (Tel12 (5’-
TAGGGTTAGGGT-3’) and Tel23 (5’ – TAGGGTTAGGGTTAGGGTTAGGG -3’)). Before use they were annealed 
in the required buffer. ctDNA was purchased from Sigma-Aldrich.  
 
CD analyses  
Circular dichroism spectra were recorded in the 230-350 nm range on a Jasco J-810 spectropolarimeter 
equipped with a Peltier temperature controller using a 10 mm path-length cell. DNA substrates were 
prepared at 4 M (strand concentration) by annealing in 10 mM Tris, 50 mM KCl, pH 7.5 with or without 
40% MPD. Spectra were acquired in the absence or presence of increasing concentrations of ligands (0-80 
µM). Observed CD signals were converted to mean residue ellipticity [Θ] = deg x cm2 x dmol-1 (Mol. Ellip.). 
 
Fluorescent Intercalator Displacement (FID) assay 
FID titrations were performed on a Perkin Elmer LS55 Luminescence equipped with thermostated cell 
holder. Spectra were acquired by using an excitation wavelength of 501 nm and recording the signal in the 
520-680 nm emission range at 25 °C. A solution containing 0.62 μM of target DNA and 1.24 μM of thiazole 
orange (TO) was prepared in a 10 mm path-length cell and the corresponding fluorescence spectrum was 
acquired in the absence and presence of increasing concentrations of tested compounds in 10 mM Tris, 50 
mM KCl, pH 7.5. The percentage of TO displacement was calculated as TO displacement = 100 - [(F/F0) × 
100], where F0 is the fluorescence in the absence of ligand and F the fluorescence recorded at each point of 
titration. TO displacement was plotted as a function of compound concentration and the EC50 (half maximal 
effective concentration) was calculated. Each titration was repeated at least in triplicate. 
 
Fluorescence melting studies 
Fluorescence melting analyses were performed with Light Cycler 480 II Roche using an excitation source at 
488 nm and recording the fluorescence emission at 520 nm. Samples (20 µl final volume) containing 0.25 
M DNA (strand concentration) were loaded on a 96-well plate in 10 mM LiOH; pH 7.5 with H3PO4, with 50 
mM KCl and increasing concentrations of ligands. Samples were first heated and cooled in the 25-95 °C 
range at a rate of 0.1 °C s-1. Then samples were maintained at 30 °C for 5 min before being slowly heated to 
95 °C (1 °C/min) and annealed at a rate of 1 °C/min. For the analyses with double strands oligonucleotides, 
the two complementary strands were annealed before ligand addition. Melting temperatures were 
determined from the first derivatives of the melting profiles using the Roche LightCycler software. Each 
curve was repeated at least in triplicate and errors were ± 0.3 °C.  
 
Crystallization  
The DNA-drug complexes were crystallized at 296 K using the sitting drop vapor diffusion method from a 
solution containing 40% MPD, 50 mM Na Cacodylate pH=6.5, 150 mM sodium fluoride and 150 mM 
potassium fluoride, on the basis of a previously reported screening [33]. Drops were equilibrated against 
the same solution. 
X-ray diffraction analyses 
Coptisine was crystallized along with the human telomeric sequence Tel12 (5’-TAGGGTTAGGGT-3’). The 
crystal of the complex belonged to the space group P43212 (tetragonal system) with cell dimensions a = b = 
41.57 Å, c = 66.17 Å. The structure was refined to Rfactor = 23.2% and Rfree factor = 25.9% to 1.55 Å resolution. 
Data collection on crystals of the DNA-drug complexes were performed at 100 K, using as cryoprotectant 
the mother liquor solution, and the synchrotron radiation at the ID29 Beamline, ESRF Grenoble. Data were 
integrated and scaled using the program XDS [34]. The structure of the Coptisine complex was solved by 
the Molecular Replacement technique using the program Phaser [35] and the coordinates of the Tel12 G-
quadruplex structure (PDB code 1K8P), [36] without all the heteroatoms, as a search model. The model was 
refined with the program Refmac5 [37] from the CCP4 program suite [38]. Manual rebuilding of the model 
was performed using the program Coot [39]. Data Collection and Refinement statistics are reported in ESI 
(Table S1). Final coordinates and structure factors have been deposited with the Protein Data Bank (PDB 
accession number 4P1D). 
Molecular Modelling 
The binding ability of Chelerythrine (iminium form) and Coptisine has been investigated toward Tel26 
hybrid-1 (PDB code: 2HY9) [40], and wtTel26 hybrid-2 (PDB code: 2JPZ) [41] telomeric G-quadruplex 
structures. Both ligand molecules have been built by the Build module of Maestro [42]. The atomic 
electrostatic charges of the ligands were calculated at the B3LYP/6-311G**+ level of theory by fitting them 
to an electrostatic potential calculated using the Jaguar software [43]. Docking calculations were performed 
using Glide [44] with the DNA structures kept fixed in their original conformations throughout the docking 
procedures. Six different grids, two of them centered nearby the guanine platforms and the other ones 
nearby the lateral grooves, were prepared for each DNA folding. For each ligand DNA complex, poses 
obtained from all the grids were collected and submitted to a minimization procedure (MacroModel [45], 
OPLS2005 [46], maximum iteration 3000 cycles, 0.05 kJ/Å-mol convergence criterion) and then sorted as a 
function of their energy content. Only poses with energy no more than 5 kcal/mol above the minimum 
were selected. In the case of the results from grids centered nearby the guanine platforms, additional 
molecular dynamics procedures were carried out (4.5 ns, T = 300 K, integration step 1.5 fs) by means of the 
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